View Single Post
Old 07-07-2011, 02:12 AM   #1
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,780
accompanying editorial re early trial results of adding everolimus to herceptin once

tumor resistant to herceptin

J Clin Oncol. 2011 Jul 5. [Epub ahead of print]
Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Can There Be Too Many Active Drugs?
Chandarlapaty S, Modi S.
Source
Memorial Sloan-Kettering Cancer Center, New York, NY.
PMID: 21730267
Lani is offline   Reply With Quote